Drug-Delivery Smart Pill Market Forecast and Scope - 2031
The Drug-Delivery Smart Pill Market is expected to register a CAGR of 11.7% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring). The report further presents analysis based on Type (Ingestible Sensors, Smart Drug Delivery Systems). The report is further segmented based on Disease Focus (Gastrointestinal Disorders, Chronic Diseases). The report further presents analysis based on End-User (Hospitals, Home Healthcare). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Drug-Delivery Smart Pill Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Drug-Delivery Smart Pill Market Segmentation
Application- Capsule Endoscopy
- Drug Delivery
- Patient Monitoring
- Ingestible Sensors
- Smart Drug Delivery Systems
- Gastrointestinal Disorders
- Chronic Diseases
- Hospitals
- Home Healthcare
- Hospitals
- Home Healthcare
Strategic Insights
Drug-Delivery Smart Pill Market Growth Drivers- Innovations in Technology: The inclusion of technologies such as microelectronics, nanotechnology, and biosensors in drug delivery systems is revolutionizing the mode of administration of medications. Smart pills can be monitored in real-time, enhance the controlled release of drugs, and improve the efficacy of treatment and compliance among patients.
- Increasing Chronic Disease Prevalence: With a rapidly increasing incidence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, there is growing acceptance and application of more advanced drug delivery systems. A smart pill is proven to be useful in better medication adherence and optimizing the therapeutic outcomes of some patients who have complex treatment regimens.
- Patient-Centric Healthcare: A vast shift in the development of drug delivery systems now comes from the acceptance of patient-centric healthcare. Smart pills present a package to help patients use drugs in easy and convenient ways, enhancing patient experience.
- Expansion of Digital Health Solutions: Increased integration of smart pills with other digital health solutions, like mobile health applications and telemedicine. These digital health solutions and smart pills combined can enhance patient monitoring and engagement for improved health outcomes.
- Emphasis on Non-Invasive Drug Delivery Methods: Trends appear to focus more on the development of non-invasive drug delivery methods, such as oral smart pills that can deliver biologics or vaccines; this may be able to expand the scope of smart pills beyond traditional pharmaceuticals.
- Increasing Demands on Personalized Medicine: There has been a growing focus on personalized medicine, by which specific treatments are given based on the needs of the patient. Smart pills could be designed to release drugs in relation to parameters specific to patients, for instance, by releasing drugs based on metabolic rates or biomarker levels, rendering them a valuable component of personalized healthcare.
- Education Programmes: The smart pill technology needs to be driven among healthcare professionals and patients. Education initiatives can help remove some of the more common myths about smart pill technologies, making these technologies popular for clinical applications.
- Research and Development Investments: The biggest investments in R&D should go towards exploring new applications of smart pills in conditions such as oncology or chronic disease management. This may include building smart pills that monitor the progression of diseases or that give combination therapies.
- Increased Regulations: With the passage of time, as smart pill technology is developed further, regulatory agencies are more likely to come up with more regulations and greater support. Such education will facilitate faster availability of new and innovative products in the marketplace.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Drug-Delivery Smart Pill Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Drug-Delivery Smart Pill Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Bio Images Research Limited, CapsoVision, Given Imaging, Intromedic, Jinshan Science and Technology, Koninklijke Philips NV Medimetrics, Medtronic PLC, Olympus Corporation, and Otsuka Pharmaceutical Co Ltd are some of the major players operating in the market.
The capsule endoscopy segment accounts for the highest revenue in application segment of the drug-delivery smart pill market in 2023.
Asia Pacific region has the highest CAGR in the drug-delivery smart pill market.
The Drug-Delivery Smart Pill Market is estimated to witness a CAGR of 11.7% from 2023 to 2031
The major factors driving the drug-delivery smart pill market are:
1. Innovations in Technology.
2. Increasing Chronic Disease Prevalence.
3. Patient-Centric Healthcare.
North America region dominated the drug-delivery smart pill market in 2023.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug-delivery Smart Pill Market - By Application
1.3.2 Drug-delivery Smart Pill Market - By Type
1.3.3 Drug-delivery Smart Pill Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG-DELIVERY SMART PILL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG-DELIVERY SMART PILL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DRUG-DELIVERY SMART PILL MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG-DELIVERY SMART PILL - GLOBAL MARKET OVERVIEW
6.2. DRUG-DELIVERY SMART PILL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG-DELIVERY SMART PILL MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CAPSULE ENDOSCOPY
7.3.1. Overview
7.3.2. Capsule Endoscopy Market Forecast and Analysis
7.4. DRUG DELIVERY
7.4.1. Overview
7.4.2. Drug Delivery Market Forecast and Analysis
7.5. PATIENT MONITORING
7.5.1. Overview
7.5.2. Patient Monitoring Market Forecast and Analysis
8. DRUG-DELIVERY SMART PILL MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. ADULT
8.3.1. Overview
8.3.2. Adult Market Forecast and Analysis
8.4. CHILDREN
8.4.1. Overview
8.4.2. Children Market Forecast and Analysis
9. DRUG-DELIVERY SMART PILL MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drug-delivery Smart Pill Market Overview
9.1.2 North America Drug-delivery Smart Pill Market Forecasts and Analysis
9.1.3 North America Drug-delivery Smart Pill Market Forecasts and Analysis - By Application
9.1.4 North America Drug-delivery Smart Pill Market Forecasts and Analysis - By Type
9.1.5 North America Drug-delivery Smart Pill Market Forecasts and Analysis - By Countries
9.1.5.1 United States Drug-delivery Smart Pill Market
9.1.5.1.1 United States Drug-delivery Smart Pill Market by Application
9.1.5.1.2 United States Drug-delivery Smart Pill Market by Type
9.1.5.2 Canada Drug-delivery Smart Pill Market
9.1.5.2.1 Canada Drug-delivery Smart Pill Market by Application
9.1.5.2.2 Canada Drug-delivery Smart Pill Market by Type
9.1.5.3 Mexico Drug-delivery Smart Pill Market
9.1.5.3.1 Mexico Drug-delivery Smart Pill Market by Application
9.1.5.3.2 Mexico Drug-delivery Smart Pill Market by Type
9.2. EUROPE
9.2.1 Europe Drug-delivery Smart Pill Market Overview
9.2.2 Europe Drug-delivery Smart Pill Market Forecasts and Analysis
9.2.3 Europe Drug-delivery Smart Pill Market Forecasts and Analysis - By Application
9.2.4 Europe Drug-delivery Smart Pill Market Forecasts and Analysis - By Type
9.2.5 Europe Drug-delivery Smart Pill Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drug-delivery Smart Pill Market
9.2.5.1.1 Germany Drug-delivery Smart Pill Market by Application
9.2.5.1.2 Germany Drug-delivery Smart Pill Market by Type
9.2.5.2 France Drug-delivery Smart Pill Market
9.2.5.2.1 France Drug-delivery Smart Pill Market by Application
9.2.5.2.2 France Drug-delivery Smart Pill Market by Type
9.2.5.3 Italy Drug-delivery Smart Pill Market
9.2.5.3.1 Italy Drug-delivery Smart Pill Market by Application
9.2.5.3.2 Italy Drug-delivery Smart Pill Market by Type
9.2.5.4 Spain Drug-delivery Smart Pill Market
9.2.5.4.1 Spain Drug-delivery Smart Pill Market by Application
9.2.5.4.2 Spain Drug-delivery Smart Pill Market by Type
9.2.5.5 United Kingdom Drug-delivery Smart Pill Market
9.2.5.5.1 United Kingdom Drug-delivery Smart Pill Market by Application
9.2.5.5.2 United Kingdom Drug-delivery Smart Pill Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drug-delivery Smart Pill Market Overview
9.3.2 Asia-Pacific Drug-delivery Smart Pill Market Forecasts and Analysis
9.3.3 Asia-Pacific Drug-delivery Smart Pill Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Drug-delivery Smart Pill Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Drug-delivery Smart Pill Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drug-delivery Smart Pill Market
9.3.5.1.1 Australia Drug-delivery Smart Pill Market by Application
9.3.5.1.2 Australia Drug-delivery Smart Pill Market by Type
9.3.5.2 China Drug-delivery Smart Pill Market
9.3.5.2.1 China Drug-delivery Smart Pill Market by Application
9.3.5.2.2 China Drug-delivery Smart Pill Market by Type
9.3.5.3 India Drug-delivery Smart Pill Market
9.3.5.3.1 India Drug-delivery Smart Pill Market by Application
9.3.5.3.2 India Drug-delivery Smart Pill Market by Type
9.3.5.4 Japan Drug-delivery Smart Pill Market
9.3.5.4.1 Japan Drug-delivery Smart Pill Market by Application
9.3.5.4.2 Japan Drug-delivery Smart Pill Market by Type
9.3.5.5 South Korea Drug-delivery Smart Pill Market
9.3.5.5.1 South Korea Drug-delivery Smart Pill Market by Application
9.3.5.5.2 South Korea Drug-delivery Smart Pill Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Drug-delivery Smart Pill Market Overview
9.4.2 Middle East and Africa Drug-delivery Smart Pill Market Forecasts and Analysis
9.4.3 Middle East and Africa Drug-delivery Smart Pill Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Drug-delivery Smart Pill Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Drug-delivery Smart Pill Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Drug-delivery Smart Pill Market
9.4.5.1.1 South Africa Drug-delivery Smart Pill Market by Application
9.4.5.1.2 South Africa Drug-delivery Smart Pill Market by Type
9.4.5.2 Saudi Arabia Drug-delivery Smart Pill Market
9.4.5.2.1 Saudi Arabia Drug-delivery Smart Pill Market by Application
9.4.5.2.2 Saudi Arabia Drug-delivery Smart Pill Market by Type
9.4.5.3 U.A.E Drug-delivery Smart Pill Market
9.4.5.3.1 U.A.E Drug-delivery Smart Pill Market by Application
9.4.5.3.2 U.A.E Drug-delivery Smart Pill Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Drug-delivery Smart Pill Market Overview
9.5.2 South and Central America Drug-delivery Smart Pill Market Forecasts and Analysis
9.5.3 South and Central America Drug-delivery Smart Pill Market Forecasts and Analysis - By Application
9.5.4 South and Central America Drug-delivery Smart Pill Market Forecasts and Analysis - By Type
9.5.5 South and Central America Drug-delivery Smart Pill Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Drug-delivery Smart Pill Market
9.5.5.1.1 Brazil Drug-delivery Smart Pill Market by Application
9.5.5.1.2 Brazil Drug-delivery Smart Pill Market by Type
9.5.5.2 Argentina Drug-delivery Smart Pill Market
9.5.5.2.1 Argentina Drug-delivery Smart Pill Market by Application
9.5.5.2.2 Argentina Drug-delivery Smart Pill Market by Type
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DRUG-DELIVERY SMART PILL MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DRUG-DELIVERY SMART PILL MARKET, KEY COMPANY PROFILES
12.1. BIO-IMAGES RESEARCH LIMITED
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CAPSOVISION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GIVEN IMAGING
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INTROMEDIC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JINSHAN SCIENCE AND TECHNOLOGY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. KONINKLIJKE PHILIPS NV (MEDIMETRICS)
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MEDTRONIC PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. OLYMPUS CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OTSUKA PHARMACEUTICAL CO. LTD,
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PROTEUS PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Bio-Images Research Limited
2. CapsoVision
3. Given Imaging
4. Intromedic
5. Jinshan Science and Technology
6. Koninklijke Philips NV (Medimetrics)
7. Medtronic PLC
8. Olympus Corporation
9. Otsuka Pharmaceutical Co. Ltd,
10. Proteus Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For